These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10969653)
1. Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma. Harrison LH; Schwarzenberger PO; Byrne PS; Marrogi AJ; Kolls JK; McCarthy KE Ann Thorac Surg; 2000 Aug; 70(2):407-11. PubMed ID: 10969653 [TBL] [Abstract][Full Text] [Related]
2. The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study. Schwarzenberger P; Harrison L; Weinacker A; Marrogi A; Byrne P; Ramesh R; Theodossiou C; Gaumer R; Summer W; Freeman SM; Kolls JK Hum Gene Ther; 1998 Nov; 9(17):2641-9. PubMed ID: 9853530 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma. Schwarzenberger P; Lei D; Freeman SM; Ye P; Weinacker A; Theodossiou C; Summer W; Kolls JK Am J Respir Cell Mol Biol; 1998 Aug; 19(2):333-7. PubMed ID: 9698607 [TBL] [Abstract][Full Text] [Related]
5. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene. Elshami AA; Kucharczuk JC; Zhang HB; Smythe WR; Hwang HC; Litzky LA; Kaiser LR; Albelda SM Hum Gene Ther; 1996 Jan; 7(2):141-8. PubMed ID: 8788165 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818 [TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for malignant pleural mesothelioma: present and future. Tada Y; Takiguchi Y; Hiroshima K; Shimada H; Ueyama T; Nakamura M; Tatsumi K; Kuriyama T; Tagawa M Oncol Res; 2008; 17(6):239-46. PubMed ID: 19192718 [TBL] [Abstract][Full Text] [Related]
9. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation. Miller BH; Rosado-de-Christenson ML; Mason AC; Fleming MV; White CC; Krasna MJ Radiographics; 1996 May; 16(3):613-44. PubMed ID: 8897628 [TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Smythe WR; Hwang HC; Elshami AA; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM Ann Surg; 1995 Jul; 222(1):78-86. PubMed ID: 7618973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]